News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,488 Results
Type
Article (8016)
Company Profile (144)
Press Release (481328)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166749)
Career Advice (304)
Deals (25738)
Drug Delivery (7)
Drug Development (52874)
Employer Resources (14)
FDA (9760)
Job Trends (8572)
News (238203)
Policy (17898)
Tag
2025 Best Places to Work (5)
2026 Best Places to Work (12)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Digital (1)
2027 Pharm Country Standard (1)
Academia (502)
Accelerated approval (31)
ADA (18)
Adcomms (1)
Allergies (103)
Alliances (33161)
ALS (122)
Alzheimer's disease (1013)
Antibody-drug conjugate (ADC) (335)
Approvals (10491)
Artificial intelligence (382)
ASCO (160)
Autoimmune disease (259)
Automation (34)
Bankruptcy (264)
Belgium (4)
Best Places to Work (6957)
BIO (36)
Biologics (59)
BIOSECURE Act (1)
Biosimilars (126)
BioSpace Insights (17)
Biotechnology (89)
Bispecific (29)
Bladder cancer (149)
Brain cancer (36)
Breast cancer (553)
Cancer (4127)
Cardiovascular disease (247)
Career advice (245)
Career pathing (1)
CAR-T (195)
CDC (2)
CDMO (36)
Celiac Disease (3)
Cell therapy (534)
Cervical cancer (37)
Clinical research (48611)
Collaboration (1380)
Commercialization (33)
Compensation (1662)
Complete response letters (36)
COVID-19 (776)
CRISPR (75)
C-suite (871)
Cystic fibrosis (89)
Data (6679)
Denatured (4)
Depression (109)
Dermatology (104)
Diabetes (387)
Diagnostics (4282)
Digital health (43)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (176)
Drug pricing (7)
Drug shortages (3)
Duchenne muscular dystrophy (176)
Earnings (74430)
Editorial (1)
Employer branding (2)
Employer resources (14)
ESMO (240)
Events (89225)
Executive appointments (743)
Eye disease (6)
FDA (12733)
Fibrodysplasia Ossificans Progressiva (12)
Fragile X (1)
Friedreich's ataxia (21)
Frontotemporal dementia (25)
Funding (1009)
Gene editing (140)
Generative AI (15)
Gene therapy (359)
GLP-1 (318)
Government (953)
Grass and pollen (2)
Guidances (287)
Healthcare (9447)
Hematology (115)
HIV (60)
Huntington's disease (29)
Idiopathic pulmonary fibrosis (5)
IgA nephropathy (82)
Immunology and inflammation (114)
Immuno-oncology (75)
Indications (188)
Infectious disease (985)
Inflammatory bowel disease (145)
Inflation Reduction Act (4)
Influenza (90)
Intellectual property (274)
Interviews (41)
IPO (12400)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (19)
Kidney disease (91)
Layoffs (59)
Legal (5195)
Licensing (63)
Liver cancer (47)
Longevity (28)
Lung cancer (587)
Lung diease (11)
Lymphoma (282)
Machine learning (30)
Management (3)
Manufacturing (629)
Marketing (24)
MASH (131)
Medical affairs (2)
Medical device (8728)
Medtech (8929)
Mergers & acquisitions (14486)
Metabolic disorders (790)
mRNA (82)
Multiple sclerosis (118)
Multispecific (3)
NASH (4)
Netherlands (4)
Neurodegenerative disease (247)
Neuropsychiatric disorders (41)
Neuroscience (1985)
Neurotech (2)
NextGen: Class of 2026 (3150)
Non-profit (844)
Obesity (246)
Opinion (10)
Ovarian cancer (184)
Pain (195)
Pancreatic cancer (235)
Parkinson's disease (219)
Partnered (12)
Patents (530)
Patient advocacy (3)
Patient recruitment (550)
Patient selection (55)
Peanut (34)
People (41573)
Peptides (23)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (15697)
Phase 2 (21740)
Phase 3 (14662)
Pipeline (8942)
Policy (20)
Postmarket research (1570)
Preclinical (6619)
Press Release (34)
Prostate cancer (211)
Psychedelics (12)
Radiopharmaceuticals (205)
Rare diseases (638)
Real estate (3025)
Recruiting (6)
Regenerative medicine (18)
Regulatory (15249)
Reports (24)
Research institute (596)
Resumes & cover letters (45)
Rett syndrome (47)
RNA editing (9)
RSV (51)
Schizophrenia (111)
Series A (179)
Series B (128)
Service/supplier (5)
Sickle cell disease (69)
Spinal muscular atrophy (93)
Sponsored (5)
Startups (2021)
Stem cells (3)
Stomach cancer (3)
Substance use disorders (17)
Supply chain (56)
Switzerland (2)
Tariffs (2)
Vaccines (361)
Venture capital (18)
Weight loss (79)
Wet AMD (3)
Women's health (101)
Date
Today (75)
Last 7 days (660)
Last 30 days (2296)
Last 365 days (19232)
2026 (17107)
2025 (19252)
2024 (22987)
2023 (26550)
2022 (34593)
2021 (37167)
2020 (33468)
2019 (23256)
2018 (17468)
2017 (18764)
2016 (17917)
2015 (24263)
2014 (21679)
2013 (18135)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (232)
Alabama (80)
Alaska (2)
Arizona (329)
Arkansas (12)
Asia (18094)
Australia (2129)
California (13325)
Canada (3441)
China (593)
Colorado (549)
Connecticut (467)
Delaware (235)
Europe (24854)
Florida (1981)
Georgia (420)
Hawaii (3)
Idaho (46)
Illinois (798)
India (66)
Indiana (339)
Iowa (19)
Japan (465)
Kansas (105)
Kentucky (34)
Louisiana (30)
Maine (27)
Maryland (1313)
Massachusetts (8732)
Michigan (325)
Minnesota (622)
Mississippi (5)
Missouri (86)
Montana (20)
Nebraska (11)
Nevada (139)
New Hampshire (61)
New Jersey (2934)
New Mexico (12)
New York (3116)
North Carolina (1412)
North Dakota (4)
Northern California (6767)
Ohio (311)
Oklahoma (15)
Oregon (17)
Pennsylvania (2486)
Puerto Rico (24)
Rhode Island (32)
South America (407)
South Carolina (81)
South Dakota (1)
Southern California (5571)
Tennessee (131)
Texas (2203)
United States (43130)
Utah (404)
Vermont (1)
Virginia (169)
Washington D.C. (39)
Washington State (1017)
West Virginia (1)
Wisconsin (83)
Wyoming (1)
489,488 Results for "abveris inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies
Enzolytics, Inc. announces a collaboration with Abveris, a division of Twist Bioscience Corporation, to discover fully human monoclonal antibodies against multiple viruses.
September 16, 2022
·
3 min read
Business
Abveris Announces Multi-Target, Multi-Year Therapeutic Antibody Discovery Collaboration with Prometheus Biosciences
Abveris today announced that Prometheus Biosciences and Abveris have entered a multi-year collaboration to develop therapeutic antibodies against multiple targets.
November 11, 2021
·
3 min read
Business
Abveris Named as One of the Best Places to Work
The Business Intelligence Group today announced that it has awarded Abveris a division of Twist Bioscience, a Best Places to Work 2022.
March 10, 2022
·
2 min read
Business
Twist Bioscience Acquires Abveris to Complement Antibody Capabilities
Twist Bioscience snapped up in vivo antibody discovery company Abveris Inc. in a deal valued at up to $190 million. The acquisition is expected to bolster Twist’s biopharma antibody capabilities.
November 22, 2021
·
2 min read
·
Alex Keown
Business
Abveris Announces Partnership with Foundery Innovations to Develop Therapeutics to Advance Immunotherapy
Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Foundery Innovations, Inc. (“Foundery Innovations”) for the discovery of monoclonal antibodies to support the development of novel biotherapeutic drugs.
July 21, 2021
·
2 min read
Deals
Twist Bioscience Enters into Definitive Agreement to Acquire Abveris, Bolstering Biopharma Capabilities
Twist Bioscience Corporation today announced it entered into a definitive agreement to acquire Abveris.
November 22, 2021
·
6 min read
Business
Abveris and Abilita Bio Announce a Discovery Collaboration to Develop Therapeutics for Challenging Membrane Protein Targets
Abveris, Inc. (“Abveris”) and Abilita Bio, Inc. announce a joint research collaboration that will leverage the synergies between their platforms to enable the discovery of novel antibodies targeting key GPCRs within the tumor immune microenvironment.
August 24, 2021
·
3 min read
Business
Abveris Announces Equity-Bearing Antibody Discovery Partnership with Saccharo
Abveris, Inc. (“Abveris”) announced today that it has entered into an antibody discovery partnership with Saccharo, Inc. (“Saccharo”) for the discovery of monoclonal antibodies to advance the Saccharo therapeutic pipeline
December 2, 2020
·
2 min read
Genetown
Abveris Deploys Second Berkeley Lights Beacon® System to Expand Single B Cell Antibody Discovery Capacity
Abveris, Inc., Boston’s leader in antibody discovery services, today announced the deployment of a second Berkeley Lights, Inc. Beacon® optofluidic system to enable expansion of the Abveris antibody discovery offering.
April 22, 2021
·
3 min read
Press Releases
Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) FY26
October 1, 2026
·
2 min read
1 of 48,949
Next
